PALO ALTO, Calif.--(BUSINESS WIRE)--Jan. 31, 2006-- Provides First Quarter 2006 Financial Guidance; Completes Acquisition of PediaMed Sales Organization Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, today reported net income for the quarter ended December 31, 2005 of $15.1 million, or $0.40 earnings per share on a diluted “If-Converted” basis. This compares with net income of $6.0 million, or $0.16 earnings per share on a diluted basis, for the comparable quarter in 2004. The results in the 2005 fourth quarter include a positive impact of $0.25 per diluted share from recording a tax asset of $9.9 million, as previously announced.
